If you have been diagnosed with adult-onset, or type 2, diabetes, chances are good that you have been prescribed Canagliflozin, sold under the trade names Invokana or Sulisent. Invokana, marketed by Janssen, a division of Johnson & Johnson, is supposed to improve sugar control in patients with type 2 diabetes. The product was approved for sale in the United States in March, 2013.
According to the U.S Food and Drug Administration (FDA), though, Invokana has been linkedto a wide range of health issues, from low blood sugar and extreme dehydration to loss of consciousness and allergic reactions. Some Invokana users have reported broken bones, pancreatitis, loss of bone density and kidney disease. The FDA also acknowledges that Invokana may increase risk of urinary tract infections and elevated cholesterol levels, as well as diabetic ketoacidosis, a potentially life-threatening condition.
If you or someone you love has suffered adverse health events after using Invokana, GetLegal has the tools and resources to help you find skilled legal representation to protect your rights. Visit our attorney directory, look for your geographic location and find the best lawyer for your situation.
Defective Drugs & Medical Devices Topics
I often am asked by clients how they can avoid probate. In some situations, it is appropriate to tak…Read More 12 Jul 2019, Friday
What is the Hatch Act and How Did Kellyanne Conway Violate It?
Office of Special Counsel Calls White House Counselor a “Repeat Offender” and Calls for…Read More 25 Jun 2019, Tuesday
TEVA Pharmaceutical Settles Opioid Lawsuit Before Trial
Israeli Drug Company Agrees to Pay $85 Million A second major pharmaceutical company has decided to…Read More 28 May 2019, Tuesday